Vimarsana
Biggest News Aggregation in the World

Page 4 - Controlled Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Controlled Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Controlled Study Today - Breaking & Trending Today

Royal Philips: TCT 2021: Philips announces new innovations and clinical data supporting the treatment of patients with cardiovascular disease - Vimarsana News

Royal Philips: TCT 2021: Philips announces new innovations and clinical data supporting the treatment of patients with cardiovascular disease

November 2, 2021 Philips debuts three new solutions in the North American market that will help drive procedural innovation and workflow efficiency, adding to the company's ecosystem of interventional

Investegate |Royal Philips Announcements | Royal Philips: TCT 2021: Philips announces new innovations and clinical data supporting the treatment of patients with cardiovascular disease - Vimarsana News

Investegate |Royal Philips Announcements | Royal Philips: TCT 2021: Philips announces new innovations and clinical data supporting the treatment of patients with cardiovascular disease

Investegate announcements from Royal Philips, TCT 2021: Philips announces new innovations and clinical data supporting the treatment of patients with cardiovascular disease

TCT 2021: Philips announces new innovations and clinical data supporting the treatment of ... - Vimarsana News

TCT 2021: Philips announces new innovations and clinical data supporting the treatment of ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Biogen Inc.: New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA (nusinersen) and Biogen's Commitment to Innovation in SMA Therapy - Vimarsana News

Biogen Inc.: New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA (nusinersen) and Biogen's Commitment to Innovation in SMA Therapy

New data analysis suggests an investigational higher dose of SPINRAZA may lead to clinically meaningful improvements in motor functionA NURTURE study analysis shows 92 percent of children who initiated

Biogen Inc.: Biogen Advances Leading Research in Spinal Muscular Atrophy (SMA) with New Data at AAN 2021 Exploring Opportunities to Improve Outcomes for Patients - Vimarsana News

Biogen Inc.: Biogen Advances Leading Research in Spinal Muscular Atrophy (SMA) with New Data at AAN 2021 Exploring Opportunities to Improve Outcomes for Patients

Biogen Inc.: Biogen Advances Leading Research in Spinal Muscular Atrophy (SMA) with New Data at AAN 2021 Exploring Opportunities to Improve Outcomes for Patients (nusinersen) Additional research reinforces the potential of biomarkers and highlights new digital tools that may help guide future treatment approaches and decisions for people with SMA CAMBRIDGE, Mass., April 19, 2021Inc. (Nasdaq: BIIB) today announced new data from the SPINRAZA (nusinersen) clinical development program aimed at optimizing outcomes for people with spinal muscular atrophy (SMA) and advancing understanding of the d...